Magneto-Electric Nanoparticles for Targeted Cell Disruption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for targeting cancer cells, viruses, and bacteria are limited by the reliance on ligands or antibodies matching specific cells, inadequate accumulation due to the Enhanced Permeability and Retention (EPR) effect, and lack of effective methods for treating antibiotic-resistant bacteria and viruses.

Innovation Solution

The use of Magneto-Electric Nano-Particles (MENPs) coated with guiding agents that bind specifically to targeted cells or viruses, combined with an external magnetic field to generate an electric field for disruption or killing, enhancing accumulation and specificity through electric gradient forces.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ligands or antibodies are used to target cancer cells, then specificity to cancer cells is improved, but availability of matching ligands or antibodies is limited

Engineering Contradiction:
Improvespecificity to cancer cellsVSAvoidavailability of matching ligands or antibodies
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the targeting mechanism from biochemical recognition (ligand-antibody binding) to physical field-based recognition (electric gradient forces acting on charged nanoparticles). By controlling the charge parameters of MENPs and applying external magnetic fields to generate electric gradients, the system achieves universal targeting capability across different cancer cell types without being limited by specific ligand availability.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If EPR effect is used to accumulate nanoparticles at cancer site, then passive accumulation is improved, but accumulation amount and density are insufficient for treatment

Engineering Contradiction:
Improvenanoparticle accumulation at cancer siteVSAvoidtreatment efficacy due to insufficient density
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent applies external magnetic fields before and during nanoparticle administration to pre-position MENPs at the cancer site and maintain their concentration. This preliminary action overcomes the passive and limited EPR effect by actively concentrating nanoparticles to therapeutic densities before treatment initiation.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces the passive physiological EPR effect (mechanical filtration through leaky vasculature) with an active magnetic field-based concentration system. This substitution enables precise control over nanoparticle accumulation density and location, achieving therapeutic concentrations that EPR alone cannot provide.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Ease of operation

If point contact electrodes are used for electrical stimulation, then localized stimulation is achieved, but uniform stimulation at cellular level cannot be achieved

Engineering Contradiction:
Improvelocalized stimulation capabilityVSAvoiduniformity of cellular-level stimulation
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent segments the stimulation field into multiple independent magnetic field sources that can be individually controlled. By using arrays of magnets or electromagnets positioned around the treatment area, the system creates a distributed pattern of electric gradients that collectively provide uniform cellular-level stimulation across the entire cancer site, eliminating the non-uniformity caused by single point electrodes.

Inventive Principle:
Principle #1Segmentation

4Reliability

If conventional methods are used to kill bacteria or viruses, then antibiotic treatment is effective, but antibiotic-resistant bacteria cannot be treated

Engineering Contradiction:
Improveeffectiveness of bacterial killingVSAvoidapplicability to antibiotic-resistant bacteria
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces biochemical antibiotic mechanisms with physical field-based killing mechanisms. By using magnetic fields to generate intense localized electric gradients that disrupt bacterial and viral structures, the system achieves killing effectiveness against antibiotic-resistant pathogens without relying on biochemical pathways that resistance can develop.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively targets and kills cancer cells, viruses, and bacteria by increasing the negative charge of MENPs, allowing for precise accumulation and electric field-induced disruption, improving treatment efficacy while minimizing harm to normal cells.

Implementation Method 1

applying a magnetic field to the GAC-MENPs to generate an electric field for disrupting or killing the targeted bacteria or viruses

Methodology Applied
Scientific EffectElectromagnetic induction: Electromagnetic Induction

Implementation Method 2

binding the targeted bacteria or viruses with the GAC-MENPs, and applying a magnetic field to the GAC-MENPs

Methodology Applied
Scientific EffectMagnetic force: Magnetic Field

Data Source

PatentUS10974060B2Methods for disrupting or killing bacteria or viruses using nanoparticles and external field
Publication Date: 2021.04.13 LIANG PING
  • US10974060B2 patent drawing
  • US10974060B2 patent drawing
  • US10974060B2 patent drawing

AI summary

This invention presents methods for targeting and killing types of cells or organisms using Magneto-Electric Nano-Particles under the control of an external magnetic field. A method was also presented for using Magneto-Electric Nano-Particles to stimulate or rejuvenate cells under an external magnetic field.